Reata Pharmaceuticals Earnings Date, Estimates & History (NASDAQ:RETA)

$196.20

-0.03 (-0.02 %)

(As of 02/25/2020 04:00 PM ET)

Add

Compare

Today's Range

$195.00

Now: $196.20▼

$201.41

50-Day Range

$191.15

MA: $214.19▼

$247.74

52-Week Range

$70.00

Now: $196.20▼

$257.96

Volume392,422 shs

Average Volume391,817 shs

Market Capitalization$5.94 billion

P/E RatioN/A

Dividend YieldN/A

Beta2.58

Reata Pharmaceuticals (NASDAQ:RETA) Earnings Information

Reata Pharmaceuticals last announced its earnings data on February 19th, 2020. The reported ($5.91) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($2.21) by $3.70. The firm had revenue of $2.67 million for the quarter, compared to the consensus estimate of $8.04 million. Its revenue for the quarter was down 68.4% compared to the same quarter last year. Reata Pharmaceuticals has generated ($9.54) earnings per share over the last year. Reata Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 14th, 2020 based off prior year's report dates.

Reata Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Reata Pharmaceuticals (NASDAQ:RETA) Earnings Estimates

2020 EPS Consensus Estimate: ($7.78)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2020	1	($1.61)	($1.61)	($1.61)
Q2 2020	1	($1.83)	($1.83)	($1.83)
Q3 2020	1	($2.03)	($2.03)	($2.03)
Q4 2020	1	($2.31)	($2.31)	($2.31)

Reata Pharmaceuticals (NASDAQ RETA) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Reported EPS	GAAP EPS	Revenue Estimate	Actual Revenue	Conference Call
5/14/2020 (Estimated)
2/19/2020	Q4	($2.21)	($5.91)	($5.91)	$8.04 million	$2.67 million	Transcript
11/12/2019	Q3	($1.25)	($1.32)	($1.32)	$7.43 million	$8.24 million	Listen
8/8/2019	Q2 2019	($1.12)	($1.1434)	($1.14)	$7.76 million	$7.83 million	N/A
5/9/2019	3/31/2019	($0.97)	($0.98)	($0.98)	$7.92 million	$7.77 million	N/A
2/28/2019	Q4 2018	($1.02)	($0.86)	($0.86)	$6.60 million	$8.45 million	N/A
11/7/2018	9/30/2018	($0.79)	($1.07)	($1.07)	$9.50 million	$5.18 million	N/A
8/8/2018	Q2 2018	($0.74)	($1.08)	($1.00)	$9.11 million	$7.57 million	N/A
5/8/2018	Q1 2018	($0.6080)	$0.1530	$0.15	$10.21 million	$32.39 million	N/A
3/2/2018	Q4 2017	($0.5630)	($0.64)	($0.64)	$11.18 million	$9.96 million	N/A
11/13/2017	Q3 2017	($0.3890)	($0.4950)	($0.50)	$12.54 million	$12.60 million	N/A
8/14/2017	Q2 2017	($0.32)	($0.52)	($0.52)	$12.58 million	$12.81 million	N/A
5/11/2017	Q1 2017	($0.11)	($0.32)	($0.32)	$12.48 million	$12.73 million	N/A
3/3/2017	Q4 2016	($0.13)	($0.19)	($0.19)	$12.49 million	$12.50 million	N/A
11/14/2016	Q3 2016	($0.18)	($0.04)	($0.04)	$12.46 million	$12.55 million	N/A
8/11/2016	Q2 2016	($0.08)	($0.05)	($0.05)		$12.40 million	N/A

(Earnings results data provided by Zacks Investment Research)

This page was last updated on 2/25/2020 by MarketBeat.com Staff

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Reata Pharmaceuticals Earnings Date, Estimates & History (NASDAQ:RETA)

Adding

Adding

Adding Reata Pharmaceuticals Inc

Earnings

Reata Pharmaceuticals (NASDAQ:RETA) Earnings Information

Reata Pharmaceuticals Earnings Estimates and Actuals by Quarter

Reata Pharmaceuticals (NASDAQ:RETA) Earnings Estimates

Reata Pharmaceuticals (NASDAQ RETA) Earnings History by Quarter

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources